NEW YORK, NY / ACCESSWIRE / March 15, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

Revive Therapeutics Ltd.
https://rdinvesting.com/news/?ticker=RVV.V

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO

Spectral Medical Inc.
https://rdinvesting.com/news/?ticker=EDT.TO

Aurinia Pharmaceuticals' stock edged 0.14% higher Wednesday, to close the day at $6.94. The stock recorded a trading volume of 29,990 shares, which was below its three months average volume of 51,423 shares. In the last year, Aurinia Pharmaceuticals' shares have traded in a range of 5.68 - 13.04. The share price has gained 22.18% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.78 is below its 200-day moving average of $7.07. Shares of Aurinia Pharmaceuticals have gained approximately 21.33 percent year-to-date.

Access RDI?s Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

On Wednesday, shares of Revive Therapeutics recorded a trading volume of 36,000 shares, which was below the three months average volume of 783,038 shares. The stock ended the day 11.32% lower at 0.23. The share price has gained 80.77% from its 52 week low with a 52 week trading range of 0.13 - 0.51. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.28 is greater than its 200-day moving average of $0.25. Shares of Revive Therapeutics have fallen approximately 43.37 percent year-to-date.

Access RDI?s Revive Therapeutics Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=RVV.V

Canopy Growth's stock moved 2.63% lower Wednesday, to close the day at $31.10. The stock recorded a trading volume of 2,841,001 shares, which was below its three months average volume of 7,281,466 shares. In the last year, Canopy Growth's shares have traded in a range of 6.58 - 44.00. The share price has gained 372.64% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $29.55 is greater than its 200-day moving average of $21.39. Shares of Canopy Growth have gained approximately 4.57 percent year-to-date.

Access RDI?s Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO

On Wednesday, shares of Spectral Medical recorded a trading volume of 12,905 shares, which was below the three months average volume of 74,818 shares. The stock ended the day flat at 0.40. The share price has gained 37.93% from its 52 week low with a 52 week trading range of 0.29 - 0.64. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.39 is greater than its 200-day moving average of $0.38. Shares of Spectral Medical have gained approximately 5.26 percent year-to-date.

Access RDI?s Spectral Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EDT.TO

Our Actionable Research on Aurinia Pharmaceuticals Inc. (TSX:AUP.TO), Revive Therapeutics Ltd. (TSXV:RVV.V), Canopy Growth Corporation (TSX:WEED.TO) and Spectral Medical Inc. (TSX:EDT.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com